131 related articles for article (PubMed ID: 14642596)
1. QSAR study on 5-lipoxygenase inhibitors using distance-based topological indices.
Agrawal VK; Bano S; Khadikar PV
Bioorg Med Chem; 2003 Dec; 11(24):5519-27. PubMed ID: 14642596
[TBL] [Abstract][Full Text] [Related]
2. Quantitative structure activity relationship (QSAR) analysis of substituted 4-oxothiazolidines and 5-arylidines as lipoxygenase inhibitors.
Choudhary AN; Kumar A; Juyal V
Mini Rev Med Chem; 2010 Jul; 10(8):705-14. PubMed ID: 20412041
[TBL] [Abstract][Full Text] [Related]
3. QSAR study on 5-lipoxygenase inhibitors based on support vector machine.
Niu B; Su Q; Yuan X; Lu W; Ding J
Med Chem; 2012 Nov; 8(6):1108-16. PubMed ID: 22779798
[TBL] [Abstract][Full Text] [Related]
4. QSAR study for the soybean 15-lipoxygenase inhibitory activity of organosulfur compounds derived from the essential oil of garlic.
Camargo AB; Marchevsky E; Luco JM
J Agric Food Chem; 2007 Apr; 55(8):3096-103. PubMed ID: 17367159
[TBL] [Abstract][Full Text] [Related]
5. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationship of organosulphur compounds as soybean 15-lipoxygenase inhibitors using CoMFA and CoMSIA.
Caballero J; Fernández M; Coll D
Chem Biol Drug Des; 2010 Dec; 76(6):511-7. PubMed ID: 21040497
[TBL] [Abstract][Full Text] [Related]
7. Active site characterization and structure based 3D-QSAR studies on non-redox type 5-lipoxygenase inhibitors.
Ul-Haq Z; Khan N; Zafar SK; Moin ST
Eur J Pharm Sci; 2016 Jun; 88():26-36. PubMed ID: 27044904
[TBL] [Abstract][Full Text] [Related]
8. QSAR classification-based virtual screening followed by molecular docking studies for identification of potential inhibitors of 5-lipoxygenase.
Shameera Ahamed TK; Rajan VK; Sabira K; Muraleedharan K
Comput Biol Chem; 2018 Dec; 77():154-166. PubMed ID: 30321850
[TBL] [Abstract][Full Text] [Related]
9. Review in quantitative structure activity relationships on lipoxygenase inhibitors.
Eleni P; Dimitra HL
Mini Rev Med Chem; 2003 Aug; 3(5):487-99. PubMed ID: 12769699
[TBL] [Abstract][Full Text] [Related]
10. Rational Use of Heterogeneous Data in Quantitative Structure-Activity Relationship (QSAR) Modeling of Cyclooxygenase/Lipoxygenase Inhibitors.
Lagunin AA; Geronikaki A; Eleftheriou P; Pogodin PV; Zakharov AV
J Chem Inf Model; 2019 Feb; 59(2):713-730. PubMed ID: 30688458
[TBL] [Abstract][Full Text] [Related]
11. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
12. Rationalization of physicochemical characters of 1,5-diarylpyrazole analogs as dual (COX-2/LOX-5) inhibitors: a QSAR approach.
Revathi S; Gupta AK; Soni LK; Kavitha S; Wagh R; Kaskhedikar SG
J Pharm Biomed Anal; 2006 Sep; 42(2):283-9. PubMed ID: 16781106
[TBL] [Abstract][Full Text] [Related]
13. QSAR Study on tadpole narcosis.
Agrawal VK; Chaturvedi S; Abraham MH; Khadikar PV
Bioorg Med Chem; 2003 Oct; 11(20):4523-33. PubMed ID: 13129588
[TBL] [Abstract][Full Text] [Related]
14. Modeling of cyclooxygenase-2 and 5-lipooxygenase inhibitory activity of apoptosis-inducing agents potentially useful in prostate cancer chemotherapy: derivatives of diarylpyrazole.
Sharma BK; Pilania P; Singh P
J Enzyme Inhib Med Chem; 2009 Apr; 24(2):607-15. PubMed ID: 18825552
[TBL] [Abstract][Full Text] [Related]
15. Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study.
Gupta A; Kumar V; Aparoy P
Curr Top Med Chem; 2018; 18(13):1075-1090. PubMed ID: 30027847
[TBL] [Abstract][Full Text] [Related]
16. QSAR study on tadpole narcosis using PI index: a case of heterogenous set of compounds.
Jaiswal M; Khadikar P
Bioorg Med Chem; 2004 Apr; 12(7):1731-6. PubMed ID: 15028264
[TBL] [Abstract][Full Text] [Related]
17. QSAR studies on psychotomimetic phenylalkylamines.
Thakur M; Thakur A; Khadikar PV
Bioorg Med Chem; 2004 Feb; 12(4):825-31. PubMed ID: 14759743
[TBL] [Abstract][Full Text] [Related]
18. A ligand-based comparative molecular field analysis (CoMFA) and homology model based molecular docking studies on 3', 4'-dihydroxyflavones as rat 5-lipoxygenase inhibitors: Design of new inhibitors.
Ahamed TKS; Muraleedharan K
Comput Biol Chem; 2017 Dec; 71():188-200. PubMed ID: 29112937
[TBL] [Abstract][Full Text] [Related]
19. Computer modeling in predicting the bioactivity of human 5-lipoxygenase inhibitors.
Zhang M; Xia Z; Yan A
Mol Divers; 2017 Feb; 21(1):235-246. PubMed ID: 27904990
[TBL] [Abstract][Full Text] [Related]
20. Exploring QSARs for 5-lipoxygenase (5-LO) inhibitory activity of 2-substituted 5-hydroxyindole-3-carboxylates by CoMFA and CoMSIA.
Zheng J; Xiao G; Guo J; Zheng Y; Gao H; Zhao S; Zhang K; Sun P
Chem Biol Drug Des; 2011 Aug; 78(2):314-21. PubMed ID: 21599857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
